| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,650 | 1,800 | 21.08. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.08. | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | - | RNS | ||
| 03.08. | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | - | RNS | ||
| 31.07. | Edison Group: Edison Issues Report on Kooth (KOO) | 527 | Newsfile | London, United Kingdom--(Newsfile Corp. - July 31, 2026) - Edison issues report on Kooth (AIM: KOO)Kooth provides clinically accredited digital mental health support, focused on children and young... ► Artikel lesen | |
| 29.07. | Kooth PLC - Half Year Trading Update | - | RNS | ||
| 26.06. | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | 1 | RNS | ||
| 23.06. | Kooth PLC - Result of 2026 Annual General Meeting | - | RNS | ||
| 21.05. | Kooth Digital Health Names Fred Bendaña Chief Commercial Officer | 457 | GlobeNewswire (Europe) | Chicago, May 21, 2026 (GLOBE NEWSWIRE) -- Kooth Digital Health announced the appointment of Fred Bendaña as Chief Commercial Officer, a role that will accelerate the growth of Soluna, Kooth's digital... ► Artikel lesen | |
| 19.05. | Kooth PLC - 2025 Annual Report and Notice of 2026 AGM | 1 | RNS | ||
| KOOTH Aktie jetzt für 0€ handeln | |||||
| 19.05. | Kooth PLC - Directorate Change | - | RNS | ||
| 20.04. | Kooth PLC - 2025 Impact Report Shows Soluna's Continued Growth | 4 | RNS | ||
| 08.04. | Kooth reports lower revenue, earnings for 2025 | 14 | Sharecast | ||
| 08.04. | Kooth says annual earnings down but highlights "strong execution" | 2 | Alliance News | ||
| 08.04. | Kooth PLC Full Year Income Declines | 1 | RTTNews | ||
| 08.04. | Kooth PLC - 2025 Full Year Results | 1 | RNS | ||
| 19.03. | Kooth PLC - Notice of Full Year Results | 3 | RNS | ||
| 12.03. | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | - | RNS | ||
| 02.03. | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | - | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,069 | +1,46 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 43,295 | +0,35 % | dailyAktien: Boston Scientific - Langfristiges Stärkesignal | ||
| PAUL HARTMANN | 201,00 | -0,50 % | Januar bis Juni 2026: PAUL HARTMANN steigert erneut Umsatz und Ergebnis | Heidenheim (ots) - - Erfolgreiches 1. Halbjahr: Umsatzerlöse steigen auf 1.252,0 Mio. EUR, organisches Umsatzwachstum von 3,3 %; bereinigtes EBITDA liegt mit 151,7 Mio. EUR um 25,9 Mio. EUR über Vorjahreswert-... ► Artikel lesen | |
| VOLITIONRX | 0,418 | +1,83 % | VOLITIONRX LTD - S-8, Securities to be offered to employees in employee benefit plans | ||
| SYSMEX | 10,535 | +2,53 % | Sysmex Corporation Announces Increase In Q1 Profit | TOKYO (dpa-AFX) - Sysmex Corporation (SSMXY.PK) revealed a profit for its first quarter that Increased, from the same period last yearThe company's bottom line totaled JPY8.691 billion, or JPY14.17... ► Artikel lesen | |
| EMBECTA | 4,640 | +3,50 % | Embecta Corp.: embecta appoints Nimish Muzumdar as SVP and President, North America | PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical... ► Artikel lesen | |
| ADDLIFE | 14,410 | +0,21 % | AddLife AB: Interim Report January 1 - June 30, 2026 | Positive development across AddLife's companies"AddLife's companies are performing well across the board, with stronger margins, good growth and increased cash flow. Ourimprovement efforts are yielding... ► Artikel lesen | |
| ENOVIS | 23,000 | +2,68 % | Enovis Corporation: Enovis Announces Second Quarter 2026 Results | Second-quarter sales growth of 3% on a reported basis, 5% organicSecond-quarter Reconstructive sales grew 8% on a reported basis, 6% organicReaffirmed full-year 2026 guidance for revenue, adjusted... ► Artikel lesen | |
| SI-BONE | 16,900 | -1,17 % | SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance | Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Quarter 2026 Financial Highlights (all comparisons are to the prior year period)... ► Artikel lesen | |
| PULMONX | 1,960 | -0,51 % | Pulmonx Corporation: Pulmonx Reports Second Quarter 2026 Financial Results | REDWOOD CITY, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| PEIJIA MEDICAL | 0,510 | -1,92 % | PEIJIA-B (09996): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 | ||
| LIFECARE ASA | 0,021 | -15,54 % | LIFE: Lifecare ASA Q2 2026 results | ||
| BACTIGUARD | 1,205 | -1,63 % | Bactiguard Holding AB: Bactiguard Holding AB's interim report second quarter 2026 | Solid performance driven by revenue growth
Second quarter 2026 (April - June)Total revenue amounted to SEK 57.1 (52.1) million, an increase of SEK 4.9 million corresponding to 9%.Net sales amounted... ► Artikel lesen | |
| SCIBASE | 1,885 | -6,68 % | SciBase: Interim report | STOCKHOLM, Aug. 19, 2026 /PRNewswire/ --
January 1 - June 30, 2026The second quarter in figures Net sales were TSEK 15,308 (8,791), +74%, cleared for currency effects +84%. ... ► Artikel lesen | |
| PHC HOLDINGS | 7,800 | 0,00 % | PHC Holdings Corporation: Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership | A pioneering pathology technology developed by Leeds Teaching Hospitals NHS Trust is set for international deployment after securing a commercial agreement with Epredia, a global leader in precision... ► Artikel lesen |